The prostate cancer treatment market is expected to grow from USD 7.22 billion in 2019 to USD 10.67 billion by 2027, at a CAGR of 5% during the forecast period 2020-2027.
Prostate cancer is a form of cancer where abnormal cells grow and invade in the prostate gland's controlled manner. It is one of the most common cancer cases after skin cancer and prevalent in geriatric men over the age of 50. Prostate cancer starts when cells in the prostate gland begins to grow out of control. Prostate cancer treatment is dependent on the stage of cancer. Some of the prostate cancer grows slowly, whereas others may require monitoring. The various diagnostics and therapeutic products used in the treatment and management of prostate cancer are prostatic adenocarcinoma, small cell carcinoma, and benign prostatic hyperplasia, and various others.
The factors driving the market are the adoption of innovative technologies in screening and diagnostic tests, incorporation of multiparametric MRI, an increase in the prevalence of prostate cancer, and the availability of new prostate cancer treatments. Poor demand for prostate cancer treatment drugs in underdeveloped countries, prolonged treatment durations, and high costs associated with tissue biopsy in advanced cancer stage will hamper the market growth. Improved R & D investment by drug innovators will provide market growth opportunities.
This study delivers a comprehensive analysis of drug type, distribution channel, and region. The drug type segment includes biological therapy, chemotherapy, hormone therapy, and others. Hormone therapy holds the largest market share, owing to the increased prevalence of prostate cancer, rising demand for hormone therapy, rise in the geriatric population, availability of generic drugs, and rise in public awareness towards prostate cancer treatment. Based on the distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies segment holds the largest market share, owing to the rise in the number of hospitalizes prostate cancer patients, the convenience offered by hospital pharmacies, and the strong presence of hospital pharmacies worldwide.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The Asia-Pacific region dominated the market, owing to the rise in the adoption of prostate cancer treatment products, increasing awareness about prostate cancer, and improvements in healthcare infrastructure. North America region is expected to witness significant growth due to the rising prevalence and high mortality rates of prostate cancer. In the region, the U.S holds the largest share, due to the large investments in R&D for the development of newer immunotherapy and drug therapies for the treatment of prostate cancer.
Some of the notable players in the market are AstraZeneca plc, Ipsen Pharms, AstellasPharma Inc., Bristol-Myers Squibb Company, Bayer AG, GlaxoSmithKline Plc., Johnson & Johnson, Takeda Pharmaceutical Company Ltd., Ferring Pharmaceuticals Inc., and Hoffmann-La Roche AG. In June 2019, IpsenPharma and Debiopharm extended their partnership for the next 15 years for Decapeptly, used for the treatment of gynecological, urcological, and pediatric conditions.
Prostate Cancer Treatment Market Analysis and Forecast, Drug Type
Prostate Cancer Treatment Market Analysis and Forecast, Distribution Channel
Prostate Cancer Treatment Market Analysis and Forecast, Region
Report Description:
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Drug Type
4.3.2. Market Attractiveness Analysis By Distribution Channel
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increase in the prevalence of prostate cancer
5.2.2. Availability of new prostate cancer treatments
5.3. Restrains
5.3.1. Prolonged treatment durations
5.4. Opportunities
5.4.1. Improved R&D investment by drug innovators
6. Global Prostate Cancer Treatment Market Analysis and Forecast, By Drug Type
6.1. Segment Overview
6.2. Biological Therapy
6.3. Chemotherapy
6.4. Hormone Therapy
6.5. Others
7. Global Prostate Cancer Treatment Market Analysis and Forecast, By Distribution Channel
7.1. Segment Overview
7.2. Hospital Pharmacies
7.3. Drug Stores & Retail Pharmacies
7.4. Online Pharmacies
8. Global Prostate Cancer Treatment Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Prostate Cancer Treatment Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Prostate Cancer Treatment Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Distribution Channel Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. AstraZeneca plc
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Ipsen Pharms
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. AstellasPharma Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Bristol-Myers Squibb Company
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Bayer AG
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. GlaxoSmithKline Plc.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Johnson & Johnson
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Takeda Pharmaceutical Company Ltd.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Ferring Pharmaceuticals Inc
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Hoffmann-La Roche AG
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
2. Global Biological Therapy, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
3. GlobalChemotherapy, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
4. GlobalHormone Therapy, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
5. GlobalOthers, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
6. Global Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
7. Global Hospital Pharmacies, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
8. Global Drug Stores & Retail Pharmacies, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
9. Global Online Pharmacies, Prostate Cancer Treatment Market, By Region, 2017-2027 (USD Billion)
10. North America Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
11. North America Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
12. U.S. Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
13. U.S. Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
14. Canada Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
15. CanadaProstate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
16. Mexico Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
17. Mexico Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
18. Europe Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
19. Europe Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
20. Germany Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
21. Germany Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
22. France Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
23. France Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
24. U.K. Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
25. U.K. Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
26. Italy Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
27. Italy Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
28. Spain Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
29. Spain Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
30. Asia Pacific Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
31. Asia Pacific Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
32. Japan Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
33. Japan Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
34. China Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
35. China Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
36. India Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
37. India Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
38. South America Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
39. South America Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
40. Brazil Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
41. Brazil Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
42. Middle East and Africa Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
43. Middle East and Africa Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
44. UAE Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
45. UAE Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
46. South Africa Prostate Cancer Treatment Market, By Drug Type, 2017-2027 (USD Billion)
47. South Africa Prostate Cancer Treatment Market, By Distribution Channel, 2017-2027 (USD Billion)
List of Figures
1. Global Prostate Cancer Treatment Market Segmentation
2. Global Prostate Cancer Treatment Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Prostate Cancer Treatment Market Attractiveness Analysis By Drug Type
9. Global Prostate Cancer Treatment Market Attractiveness Analysis By Distribution Channel
10. Global Prostate Cancer Treatment Market Attractiveness Analysis By Region
11. Global Prostate Cancer Treatment Market: Dynamics
12. Global Prostate Cancer Treatment Market Share by Drug Type(2020 & 2027)
13. Global Prostate Cancer Treatment Market Share by Distribution Channel (2020 & 2027)
14. Global Prostate Cancer Treatment Market Share by Regions (2020 & 2027)
15. Global Prostate Cancer Treatment Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.